OrthoPediatrics Corp. (KIDS)
23.64
-1.36 (-5.44%)
At close: Jan 14, 2025, 3:59 PM
22.10
-6.51%
Pre-market Jan 15, 2025, 04:05 AM EST
undefined% (undefined)
| Bid | 9.48 |
| Market Cap | 572.46M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.26 |
| PE Ratio (ttm) | -18.76 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 37.44 |
| Volume | 249,180 |
| Avg. Volume (20D) | 222,467 |
| Open | 26.00 |
| Previous Close | 25.00 |
| Day's Range | 22.68 - 26.00 |
| 52-Week Range | 21.02 - 35.99 |
| Beta | undefined |
About KIDS
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, Pe...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 13, 2017
Employees 247
Stock Exchange NASDAQ
Ticker Symbol KIDS
Website https://www.orthopediatrics.com
Analyst Forecast
According to 5 analyst ratings, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is $40, which is an increase of 69.20% from the latest price.
Buy 80.00%
Hold 20.00%
Sell 0.00%
Next Earnings Release
OrthoPediatrics Corp. is scheduled to release its earnings on Mar 5, 2025,
during market hours.
Analysts project revenue of $50.43M, reflecting a 34.08% YoY growth and earnings per share of -0.33, making a 43.48% increase YoY.
Analysts project revenue of $50.43M, reflecting a 34.08% YoY growth and earnings per share of -0.33, making a 43.48% increase YoY.
10 months ago ·
Source
+6.64%
OrthoPediatrics shares are trading higher after th...
Unlock content with
Pro Subscription
